Cargando…

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status

Human kallikrein 14 (KLK14) is a steroid hormone-regulated member of the tissue kallikrein family of serine proteases, for which a prognostic and diagnostic value in breast cancer has been suggested. To further characterise the value of KLK14 as a breast tumour marker, we have carefully analysed KLK...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fritzsche, F, Gansukh, T, Borgoño, C A, Burkhardt, M, Pahl, S, Mayordomo, E, Winzer, K-J, Weichert, W, Denkert, C, Jung, K, Stephan, C, Dietel, M, Diamandis, E P, Dahl, E, Kristiansen, G
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361186/ https://www.ncbi.nlm.nih.gov/pubmed/16434994 http://dx.doi.org/10.1038/sj.bjc.6602956

Ejemplares similares

Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma
por: Rückert, F, et al.
Publicado: (2008)

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy
por: Weichert, W, et al.
Publicado: (2008)

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis
por: Yousef, G M, et al.
Publicado: (2002)

The use of kallikrein-related peptidases as adjuvant prognostic markers in colorectal cancer
por: Talieri, M, et al.
Publicado: (2009)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer
por: Yousef, G M, et al.
Publicado: (2002)

Human kallikrein gene 13 (KLK13) expression by quantitative RT–PCR: an independent indicator of favourable prognosis in breast cancer
por: Chang, A, et al.
Publicado: (2002)

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies
por: Schmitt, Manfred, et al.
Publicado: (2013)

High expression of RelA/p65 is associated with activation of nuclear factor-κB-dependent signaling in pancreatic cancer and marks a patient population with poor prognosis
por: Weichert, W, et al.
Publicado: (2007)

Expression of lysophosphatidic acid acyltransferase beta (LPAAT-β) in ovarian carcinoma: correlation with tumour grading and prognosis
por: Niesporek, S, et al.
Publicado: (2005)

Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer
por: Gong, Weiwei, et al.
Publicado: (2020)

Development of Chemical Tools to Monitor Human Kallikrein 13 (KLK13) Activity
por: Gruba, Natalia, et al.
Publicado: (2019)

GOLPH2 protein expression as a novel tissue biomarker for prostate cancer: implications for tissue-based diagnostics
por: Kristiansen, G, et al.
Publicado: (2008)

Endogenous myoglobin in human breast cancer is a hallmark of luminal cancer phenotype
por: Kristiansen, G, et al.
Publicado: (2010)

Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes
por: Tamir, Ayala, et al.
Publicado: (2014)

Role of human tissue kallikrein in gastrointestinal stromal tumour invasion
por: Dominek, P, et al.
Publicado: (2010)

Molecular cloning of novel transcripts of human kallikrein-related peptidases 5, 6, 7, 8 and 9 (KLK5 – KLK9), using Next-generation sequencing
por: Adamopoulos, Panagiotis G., et al.
Publicado: (2017)

Kallikrein-Related Peptidase 12 (KLK12) in Breast Cancer as a Favorable Prognostic Marker
por: Sato, Ai, et al.
Publicado: (2023)

Kallikrein gene downregulation in breast cancer
por: Yousef, G M, et al.
Publicado: (2004)

Kallikrein-related peptidase-4 (KLK4): role in enamel formation and revelations from ablated mice
por: Bartlett, John D., et al.
Publicado: (2014)

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
por: Gupta, A, et al.
Publicado: (2010)

Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
por: Silva, Lakmali Munasinghage, et al.
Publicado: (2017)

AB73. Effect of human tissue kallikrein 1(hKLK1) on penile erectile function in the aged rat
por: Liu, Ji-Hong
Publicado: (2014)

Genetically-modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)-based targeted therapy (Review)
por: Devetzi, Marina, et al.
Publicado: (2018)

Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer
por: Ohlsson, L, et al.
Publicado: (2012)

KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma
por: White, N M A, et al.
Publicado: (2009)

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
por: Shan, S J C, et al.
Publicado: (2007)

Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival
por: Pitkin, L, et al.
Publicado: (2007)

Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
por: Darb-Esfahani, S, et al.
Publicado: (2012)

Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma
por: Gattolliat, C-H, et al.
Publicado: (2011)

Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis
por: Wang, Lishan
Publicado: (2013)

Prognostic value of kallikrein-related peptidase 12 (KLK12) mRNA expression in triple-negative breast cancer patients
por: Gong, Weiwei, et al.
Publicado: (2020)

The promoter and the enhancer region of the KLK 3 (prostate specific antigen) gene is frequently mutated in breast tumours and in breast carcinoma cell lines
por: Majumdar, S, et al.
Publicado: (1999)

Biochemical pathways mediated by KLK6 protease in breast cancer
por: Pampalakis, Georgios, et al.
Publicado: (2019)

Expression of the chemokine CXCL14 in the tumour stroma is an independent marker of survival in breast cancer
por: Sjöberg, Elin, et al.
Publicado: (2016)

Correction: Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis
por: Wang, Lishan
Publicado: (2013)

Retraction: Association of Polymorphism rs198977 in Human Kallikrein-2 Gene (KLK2) with Susceptibility of Prostate Cancer: A Meta-Analysis
Publicado: (2016)

Prospective quantitative gene expression analysis of kallikrein-related peptidase KLK10 as a diagnostic biomarker for childhood acute lymphoblastic leukemia
por: Ahmad, Shwan Majid, et al.
Publicado: (2022)

The BH3 mimetic HA14-1 enhances 5-fluorouracil-induced autophagy and type II cell death in oesophageal cancer cells
por: Nyhan, M J, et al.
Publicado: (2012)

Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissue
por: Luo, L-Y, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_8d426ecm8v799bhia4cleitlj0